PMI
Picard Medical, Inc.
$0.2582
-19.31%
$29.5M
No data for this timeframe.
Vol
Market Cap$29.5M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$165.8K
Inst. Activity4 buys / 0 sells
Reddit Sentiment53° Neutral
SEC Reports12
Press Releases3
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0002030617·Prev Close $0.3200
Recent Activity
Jun 2, 2026
SEC
Picard Medical terminated CFO Bernard Skaggs effective June 1, 2026, and appointed Georgina Smith as Chief Accounting Of
8-K — Impact 5/10
Jun 1, 2026
SEC
The SEC declared effective Picard Medical's S-1 registration (File No. 333-296060) on May 29, 2026, covering 16.2M share
EFFECT — Impact 5/10
May 29, 2026
SEC
Picard Medical issued a shareholder letter from Chairman Richard Fang recapping 2025 results ($4.9M revenue, +12.5% YoY)
8-K — Impact 6/10
Inst.
FMR LLC — NEW
29,112 shares ($50.9K)
Inst.
VANGUARD GROUP INC — NEW
28,145 shares ($49.3K)
Jun 3, 2026
short_volume
Short Volume: PMI — 56.9% short (47.4M / 83.5M)
Short: 47,449,733 | Exempt: 1,824,891 | TRF Vol: 83,456,241 | Short Ratio: 56.9% | Off-exchange volu
Jun 2, 2026
Press
Picard Medical announced successful completion of an acute in vivo implant study for its next-generation Emperor Total A
Impact 6/10
May 29, 2026
Press
Picard Medical issued a shareholder letter highlighting 85% Q1 revenue growth to $1.2M, positive gross margin of 24% (vs
Impact 4/10
Analyst Ratings
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 3, 2026 | HC Wainwright & Co. | REITERATE | Neutral → Neutral |
| May 18, 2026 | HC Wainwright & Co. | INITIATE | Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.03 | $-0.03 — $-0.03 | 1 | |
| Next Q | $-0.03 | $-0.03 — $-0.03 | 1 | |
| Current FY | $-0.17 | $-0.17 — $-0.17 | 77% YoY | 1 |
| Next FY | $-0.09 | $-0.09 — $-0.09 | 1 |
Latest Reports
BULLISH
Press
6/10
Picard Medical announced successful completion of an acute in vivo implant study for its next-generation Emperor Total A
Jun 2, 2026
BEARISH
8-K
5/10
Picard Medical terminated CFO Bernard Skaggs effective June 1, 2026, and appointed Georgina Smith as Chief Accounting Of
Jun 2, 2026
BEARISH
EFFECT
5/10
The SEC declared effective Picard Medical's S-1 registration (File No. 333-296060) on May 29, 2026, covering 16.2M share
Jun 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | $50.9K | NEW |
| VANGUARD GROUP INC | $49.3K | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $28.2K | NEW |
| MORGAN STANLEY | $20.2K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $9.6K | — |
Reddit Sentiment
53°▼
Neutral
Bearish
Neutral
Bullish
6 institutional holders with $165.8K total value (94,737 shares) as of 2025-Q4. Top holders: FMR, VANGUARD, CHARLES. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | 29,112 | $50.9K | 30.7% | NEW |
| 2 | VANGUARD GROUP INC | 28,145 | $49.3K | 29.7% | NEW |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 16,130 | $28.2K | 17.0% | NEW |
| 4 | MORGAN STANLEY | 11,553 | $20.2K | 12.2% | DOUBLED +128.3% |
| 5 | WELLS FARGO & COMPANY/MN | 5,459 | $9.6K | 5.8% | — |
| 6 | BANK OF AMERICA CORP /DE/ | 4,338 | $7.6K | 4.6% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | NEW | — | 29,112 | — | $50.9K | 2025-Q4 |
| VANGUARD GROUP INC | NEW | — | 28,145 | — | $49.3K | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 16,130 | — | $28.2K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 5,060 | 11,553 | +128.3% | $20.2K | 2025-Q4 |
| UBS Group AG | NEW | — | 5,483 | — | $46.6K | 2025-Q3 |
| MORGAN STANLEY | NEW | — | 5,060 | — | $43.0K | 2025-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
12 SEC filing reports analyzed. Sentiment: 1 bullish, 6 bearish, 1 mixed, 4 neutral. Avg impact: 5.4/10.
BEARISH
8-K
5/10
Picard Medical terminated CFO Bernard Skaggs effective June 1, 2026, and appointed Georgina Smith as
Jun 2, 2026
BEARISH
EFFECT
5/10
The SEC declared effective Picard Medical's S-1 registration (File No. 333-296060) on May 29, 2026,
Jun 1, 2026
MIXED
8-K
6/10
Picard Medical issued a shareholder letter from Chairman Richard Fang recapping 2025 results ($4.9M
May 29, 2026
BEARISH
PRESS-RELEASE
7/10
Picard Medical reported Q1 2026 revenue of $1.2M (85% YoY growth), gross profit turned positive at $
May 21, 2026
NEUTRAL
S-1
4/10
Picard Medical filed an S-1 to register 16.2M shares for resale by selling stockholders, including w
May 20, 2026
BEARISH
424B4
8/10
Picard Medical priced a best-efforts offering of 16.7M common shares and warrants at $0.30/unit, rai
May 6, 2026
BEARISH
8-K
8/10
Picard Medical priced a $5M registered offering of 16,666,667 common stock units at $0.30/unit, each
May 5, 2026
BULLISH
8-K
7/10
Picard Medical reported preliminary unaudited revenue of $1.1 million for Q1 2026, a 79.9% increase
Apr 22, 2026
BEARISH
8-K
6/10
Picard Medical raised $500,000 through a convertible note with Quick Capital, LLC, accompanied by a
Apr 13, 2026
NEUTRAL
8-K
3/10
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Picard
Mar 13, 2026
NEUTRAL
8-K
3/10
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Picard
Mar 13, 2026
NEUTRAL
8-K
3/10
Picard Medical, Inc. announced its participation in the inaugural 'Hands-On Training Day' at the Tec
Feb 26, 2026
BULLISH
6/10
Picard Medical announced successful completion of an acute in vivo implant study for its next-genera
Jun 2, 2026
NEUTRAL
4/10
Picard Medical issued a shareholder letter highlighting 85% Q1 revenue growth to $1.2M, positive gro
May 29, 2026
MIXED
6/10
Picard Medical reported 2025 full-year results with 12.5% revenue growth to $4.94 million, driven by
Mar 25, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.03 | $-0.03 | $-0.03 | — | — | — | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$-0.03 | $-0.03 | $-0.03 | — | — | — | $0.0B | — | 1 |
| Current FY 2026-12-31 |
$-0.17 | $-0.17 | $-0.17 | 77.3% | — | — | $0.0B | — | 1 |
| Next FY 2027-12-31 |
$-0.09 | $-0.09 | $-0.09 | — | — | — | $0.0B | 7.3% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.030 | |
| 7d ago | $-0.030 | |
| 30d ago | $0.000 | -0.030 |
| 60d ago | $0.000 | -0.030 |
| 90d ago | $0.000 | -0.030 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 3, 2026 | HC Wainwright & Co. | REITERATE | Neutral | Neutral |
| May 18, 2026 | HC Wainwright & Co. | INITIATE | — | Neutral |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
53°
Neutral
Bearish
Neutral
Bullish
12 mentions
4 bullish
3 bearish
11 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 4, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 7, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 7, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 25, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 25, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 31, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 24, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 23, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 4, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| Mar 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
Flash PMI expectations & impact on gold (XAUUSD)?
▲ 1
💬 0
⚡ 0.5
Anyone trades Flash PMI?
▲ 1
💬 0
⚡ 0.5
Jun 3, 2026
short_volume
Short Volume: PMI — 56.9% short (47.4M / 83.5M)
Short: 47,449,733 | Exempt: 1,824,891 | TRF Vol: 83,456,241 | Short Ratio: 56.9% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
fda
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
<p align="center"><em>— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures — </em></p>
Jun 2, 2026
short_volume
Short Volume: PMI — 59.2% short (111.9M / 189.0M)
Short: 111,936,444 | Exempt: 3,434,871 | TRF Vol: 189,004,862 | Short Ratio: 59.2% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: PMI — 58.3% short (6.4M / 11.0M)
Short: 6,420,017 | Exempt: 155,985 | TRF Vol: 11,006,273 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
May 29, 2026
activist
PICARD MEDICAL, INC. Issues Letter to Shareholders
<p>TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of
May 29, 2026
short_volume
Short Volume: PMI — 63.2% short (2.7M / 4.2M)
Short: 2,655,948 | Exempt: 70,263 | TRF Vol: 4,205,331 | Short Ratio: 63.2% | Off-exchange volume (dark pool + OTC)
May 21, 2026
earnings
Picard Medical / SynCardia Reports First Quarter 2026 Financial Results
<p align="center"><em>–</em> <em>Gross profit turns positive; Company executes significant debt reduction –</em></p>
May 21, 2026
short_volume
Short Volume: PMI — 60.2% short (1.8M / 3.0M)
Short: 1,788,762 | Exempt: 317,518 | TRF Vol: 2,968,902 | Short Ratio: 60.2% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: PMI — 61.5% short (2.2M / 3.5M)
Short: 2,154,203 | Exempt: 327,692 | TRF Vol: 3,504,691 | Short Ratio: 61.5% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: PMI — 60.3% short (55.5M / 92.1M)
Short: 55,515,256 | Exempt: 7,233,629 | TRF Vol: 92,106,455 | Short Ratio: 60.3% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_volume
Short Volume: PMI — 65.0% short (1.3M / 2.0M)
Short: 1,322,319 | Exempt: 0 | TRF Vol: 2,033,054 | Short Ratio: 65.0% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: PMI — 55.9% short (1.4M / 2.5M)
Short: 1,379,804 | Exempt: 4,340 | TRF Vol: 2,470,129 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_volume
Short Volume: PMI — 73.9% short (0.7M / 0.9M)
Short: 701,014 | Exempt: 2,576 | TRF Vol: 948,813 | Short Ratio: 73.9% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_interest
FTD: PMI — 1,486,797 shares ($0.7M) failed to deliver
Settlement: 20260501, Price: $0.46, FTD Value: $683,926.62, PICARD MED INC COM
Apr 30, 2026
other
Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology
Banner Health has performed more than 50 SynCardia Total Artificial Heart implants, establishing itself as a leading center in total artificial heart